PR Newswire Clinical TrialsOriginal article
Lexitas Pharma Services and Ocusun Enroll First Patient in a Pilot Study for an Upcoming Phase III Clinical Trial Evaluating Investigational Eye Drop for Age-Related Cataract
Trial StartInvestigational Eye DropPositive
AI Analysis
Summary
Lexitas Pharma Services and Ocusun enrolled the first patient in a pilot study for an upcoming Phase III clinical trial evaluating an investigational eye drop for age-related cataracts in a multicenter U.S. study.
Clinical Trial Data
Phase
Phase III (pilot)
Patients
1
Outcome Details
First patient enrolled in pilot study for Phase III clinical trial
Importance:4/10
Sentiment:
0.40
ophthalmologyclinical trialeye dropcataractPhase III
Read the original article
Published by PR Newswire Clinical Trials on July 14, 2026 12:01 PM